Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class ASSE: 603707

Semi-annual Evaluation Report on "Corporate Value and Return Enhancement" Action Plan 2025

· Issued by Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Semi-annual Evaluation Report on "Corporate Value and Return Enhancement" Action Plan 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment